TAIPEI, Dec. 26, 2025 /PRNewswire/ — TutorABC Group today announced a major upgrade to its corporate training portfolio with the launch of Oxford Business English, a specialized curriculum series designed to enhance professional communication across 12 key industries. This strategic initiative targets the growing demand from global enterprises for high-precision language training that goes beyond general fluency.

As multinational corporations continue to integrate their global teams, the need for sector-specific communication skills has surged. TutorABC Group’s new program directly addresses this by equipping professionals with the exact vocabulary, scenarios, and soft skills required in their specific fields.

*Enjoy the 7 Day Free Trial: https://www.tutorabc.com/count.asp?code=0L8nurgrAP

From “General English” to “Vertical Proficiency”

The Oxford Business English integrates authoritative materials from Oxford University Press with TutorABC Group’s proprietary AI-matching technology. The curriculum is divided into three strategic pillars covering 12 specialized pathways:

• Technology & Engineering: Manufacturing, Automotive, Tech, Logistics.
• Corporate Functions: Finance, Banking, Sales & Marketing, Customer Service.
• Service Excellence: Hospitality, Healthcare, Retail, Aviation.

Each Oxford Business English program builds real workplace communication skills through:

• Industry Language Essentials: Key terms and expressions used in the field.
• Workplace Scenarios: Meetings, client interactions, and daily communication practice.
• Practical Skills: Presenting, negotiating, writing emails, and working with global teams.
• AI-Personalized Learning: AI recommends the right teacher, lessons, and exercises.
• Progress Tracking: Clear feedback and measurable improvement.

Samuel Yang, Co-Chairman and CEO of TutorABC Group, stated, “In today’s global business environment, ‘being fluent’ is no longer enough. An engineer needs to explain technical specifications; a banker needs to negotiate complex terms. With Oxford Business English, we are moving from teaching English to teaching business execution in English. This is how we empower our clients to compete globally.”

*Enjoy the 7 Day Free Trial: https://www.tutorabc.com/count.asp?code=0L8nurgrAP

Trusted by Industry, Built for Global Mobility

Already the preferred partner for over 3,000 enterprises—including Apple, Mercedes-Benz, Shiseido, and Sheraton—TutorABC Group’s specialized curricula bridge the gap between corporate requirements and individual career goals. Whether upskilling teams in the Technology and Luxury sectors or preparing professionals for work visas in Australia and the UK, the program ensures learners master the practical negotiation and presentation skills essential for the international stage.

Rodney Miles, Co-Chairman of TutorABC Group, stated, “These specialized pathways represent a long-term investment in building sustainable professional capabilities. We don’t believe in one-size-fits-all learning. From organizations developing future-ready teams to individuals navigating global career transitions, our role is to provide structured, role-specific pathways that turn learning into measurable professional growth.”

*Enjoy the 7 Day Free Trial: https://www.tutorabc.com/count.asp?code=0L8nurgrAP

About TutorABC Group

• Global Education Group: A Global leader in online English and Chinese education with over 20 years of experience, serving learners in more than 100 countries.
• Proven Scale & Trust: Serving 100 million learners, supported by 35,000+ teachers and trusted by 3,000+ corporate clients, including Apple, Google, Microsoft, TSMC, HSBC, and PwC.
• Academic & Industry Recognition: First online education provider in Asia-Pacific to receive the highest-level WASC accreditation (2025).
• Technology & Innovation: US$300 million invested in R&D with 19 patented technologies powering AI-driven learning.
• Global Footprint: Headquartered in Hong Kong with offices worldwide, partnering with Oxford, Cambridge, National Geographic Learning, Kaplan, ETS, and Barron’s.

*Enjoy the 7 Day Free Trial: https://www.tutorabc.com/count.asp?code=0L8nurgrAP

NASHVILLE, Tenn., Dec. 26, 2025 /PRNewswire/ — LLVision has served as the industry partner on an international research project that received the AIS Impact Award 2025. The award, announced at the ICIS 2025 Conference in Nashville, recognizes the use of augmented reality technology to improve communication access for people who are deaf or hard of hearing.

The project was developed in collaboration with academic teams from Erasmus University, Tsinghua University, and other international research institutions. Rather than focusing solely on laboratory studies, the work addressed everyday communication scenarios by combining academic research with applied engineering.

This emphasis on real-world application aligns with the criteria of the AIS Impact Award, which recognizes information systems research with demonstrated societal and business impact. The Awards Committee said the project stood out for bridging academic research and practical deployment, translating accessibility research into commercially available assistive technology.

Led by Professor Li Ting of Erasmus University, the research team conducted five years of empirical experiments and field studies. The findings showed that AR-based solutions improved communication efficiency by up to 40 percent, significantly outperforming conventional smartphone-based assistive tools. Researchers said displaying speech as visual text within the user’s field of view helps preserve conversational flow. According to the World Health Organization, more than 430 million people worldwide are deaf or hard of hearing.

As part of the project, LLVision provided its AR subtitle glasses, first introduced as Leion Hey and later expanded with the second-generation Leion Hey2. Unlike smartphone-based speech-to-text applications, the glasses allow users to follow conversations without looking down at a screen, supporting more natural face-to-face interaction.

Commenting on the recognition, Dr. Wu Fei, founder and CEO of LLVision, said the award reflects growing recognition that assistive technologies must balance technical performance with human experience. He added that developers have a responsibility to ensure technology enhances dignity and inclusion rather than adding friction to everyday communication.

The technology also received international recognition in 2022, when the AR subtitle glasses category was honored with a UNESCO Netexplo Innovation Award (Top 10). LLVision said the solution is entering wider commercial deployment across workplaces, classrooms, and community settings. The company added that Leion Hey2 will be introduced to the U.S. market at CES 2026.

About LLVision

Founded in 2014, LLVision has spent more than a decade developing integrated AI and AR software-hardware solutions focused on real-world, multilingual communication. Its consumer AR translation glasses, Leion Hey2, support real-time translation across more than 100 languages, addressing the needs of international conferences, cross-border collaboration, and global travel.

KUALA LUMPUR, Malaysia, Dec. 26, 2025 /PRNewswire/ — The ESG Malaysia Summit 2025 has successfully concluded, bringing together policymakers, business leaders, industry practitioners, and sustainability experts to advance Environmental, Social and Governance (ESG) adoption across Malaysia and ASEAN, and address the evolving ESG landscape shaping ASEAN’s competitiveness, export readiness, and long-term resilience.

A key milestone of the Summit was the formal exchange of a Letter of Intent (LOI) between ESG Malaysia and the Malaysia Steel Institute (MSI), marking a strategic collaboration to accelerate ESG readiness and adoption within Malaysia’s steel and metal sector. Led by YBrs. Mr. Steven Lee, President of ESG Malaysia, and Ts. Dr. Nurul Muiz Murad, CEO of MSI, the partnership focuses on embedding ESG principles into one of ASEAN’s most critical manufacturing industries.

The LOI reflects Malaysia’s growing commitment to responsible industrial development and supports its role as a reference for ESG integration in heavy industries across ASEAN, in response to increasing global expectations on sustainability and climate disclosure in international markets.

Aligning ASEAN Businesses with Global Sustainability Expectations

The ESG Malaysia Summit 2025 addressed critical regional themes, including supply chain transparency, climate risk, sustainability reporting, and the alignment of ASEAN businesses with international frameworks such as IFRS S1 and S2, as well as emerging climate-related trade and disclosure requirements.

Karl Godderis, CEO of EUROCHAM Malaysia, commented:
“The Summit created a timely dialogue between Malaysia’s domestic sustainability priorities and the sustainability expectations of international markets. This is especially relevant as ASEAN economies navigate evolving trade agreements and global climate commitments.”

Christopher Ng, Chairman of Digitalisation at SAMENTA and representative of Trinity42, added:
“The Summit delivered valuable market intelligence for businesses operating across ASEAN. Discussions on future-proofing operations and digitalisation strongly aligned with how companies must adapt to the region’s next phase of growth.”

Yazmin Islahudin, Head of Sustainability, EDOTCO Group, highlighted the importance of continued engagement:
“As the sustainability landscape evolves at an unprecedented pace, ongoing dialogue is essential. The ESG Summit provides a vital platform for industries, regulators, and partners to remain aligned as expectations change. EDOTCO is honoured to contribute and looks forward to continuing our role in shaping the sustainability agenda with ESG Malaysia.”

Participants consistently highlighted the Summit’s practical focus and strong engagement, noting its value in translating ESG commitments into actionable strategies across diverse ASEAN markets.

Regional Collaboration at the Core

Supported by an extensive ecosystem — including EUROCHAM Malaysia, SME Corp. Malaysia, CanCham Malaysia, SAMENTA, Climate Governance Malaysia, the Energy Industries Council (EIC), Eco-Business, Malaysia Steel Institute (MSI), Orbis Business School, and GEDS — the Summit demonstrated the importance of public-private collaboration in advancing ESG adoption across ASEAN.

Sustaining ASEAN ESG Momentum

Founded in 2022, ESG Malaysia continues to play a critical role in advancing ESG awareness, climate risk mitigation, and practitioner capability development beyond national borders. Key post-Summit initiatives include:

• Expansion of the ESG Malaysia Education Hub, supporting ASEAN professionals with certified training in sustainability accounting, assurance, and climate reporting
• Development of sector-specific ESG programmes relevant to regional manufacturing, SMEs, and exporters
• Progress toward forming an ASEAN ESG Alliance, with strategic partners in mainland China, Taiwan region, Korea, and Japan, strengthening Asia-wide ESG cooperation and knowledge exchange
• Establishment of a dedicated ESG Malaysia Secretariat Office to support structured regional engagement

PR Newswire is the sponsored media of ESG Malaysia Summit 2025.

About ESG Malaysia 

ESG Malaysia is a non-profit organisation dedicated to advancing environmental, social, and governance (ESG) practices across Malaysia and ASEAN. Through advocacy, partnerships, and capacity-building, ESG Malaysia empowers public, private, and non-profit sectors to strengthen sustainability frameworks, align with global standards, and build a climate-resilient, inclusive economy.

– Secured a total of 55 million in R&D funding, including 40 million in upfront payment and 15 million in equity investment

– Accelerating R&D on core technologies, including expansion of indications for the Grabody platform

SEOUL, South Korea, Dec. 26, 2025 /PRNewswire/ — ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive a USD 40 million upfront payment for the license, research and collaboration agreement for its Grabody platform, and a USD 15 million equity investment from Eli Lilly and Company (“Lilly”).

ABL Bio and Lilly are currently conducting joint research and development on multiple therapeutic candidates leveraging the Grabody platform across various modalities.

In parallel with strengthening its collaboration with Lilly, ABL Bio plans to accelerate R&D on its core technologies—including the bispecific antibody platform ‘Grabody’, bispecific ADCs, and dual-payload ADCs—using the newly secured funding.

Sang Hoon Lee, CEO of ABL Bio said, “With the completion of the relevant administrative procedures, including the HSR Act, ABL Bio will receive the upfront payment and equity investment from Lilly. The company plans to use the newly secured funding to expand the indications of its Grabody platform into high-unmet-need areas such as obesity and muscle disorders. ABL Bio also intends to extend clinical development of its bispecific immuno-oncology candidates into combination therapies and focus on advancing next-generation ADC programs.”

Meanwhile, on November 12 and 14, ABL Bio signed a license, research and collaboration agreement for Grabody platform with Lilly valued at USD 2.602 billion (including a USD 40 million upfront payment), as well as a USD 15 million equity investment agreement. Based on these agreements, ABL Bio explores a broad range of collaborative opportunities with Lilly to develop therapies from a long-term perspective.

About ABL Bio

ABL Bio is developing various clinical and non-clinical assets based on its bispecific antibody platform ‘Grabody’. Clinical projects for 8 pipelines, including ABL301 (SAR446159), ABL001 (tovecimig), ABL111 (givastomig), ABL503 (ragistomig), ABL105 (YH32367), ABL104 (YH32364), ABL103, and ABL202 (CS5001/LCB71), are underway for different indications in various countries, including the United States, China, Australia, and Korea. Following the completion of the Phase 1 clinical trial of ABL301 (SAR446159), Sanofi will conduct the subsequent clinical studies. ABL001 (tovecimig) has received Fast Track designation by the U.S. Food and Drug Administration (FDA). In addition, ABL111 (givastomig), co-developed with NovaBridge, has presented encouraging data from the Phase 1b clinical trial evaluating the triple combination therapy with nivolumab and chemotherapy in ESMO GI 2025. In addition, ABL Bio is continuously researching and developing several other product candidates, including bispecific antibody-drug conjugates (ADCs).